Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Quanterix CorpQTRX · Entity 6649 | SVP R&D and CTO | March 23, 2022 | March 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Quanterix Corp
Report date March 23, 2022 · Filed March 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,730 |
Reported balance
After 2022-03-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-23 · Sale · Disposed 3,266 · Balance 54,730 F1: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2021. F2: Includes 7,287 restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2021.
F2: Includes 7,287 restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2019 Filed Oct 21, 2019 21:22 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $20.32 | $33,872.77 |
DisclosureSEC source: 0001562180-19-005204 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.28 to $20.36. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 9,177 restricted stock units. Read SEC document |
| October 21, 2019 Filed Oct 21, 2019 21:22 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,667 | $1.93 | $3,217.31 |
DisclosureSEC source: 0001562180-19-005204 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:55 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-004848 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,942 Underlying: Common Stock · 1,667 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option is fully vested. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:55 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $25.68 | $42,808.56 |
DisclosureSEC source: 0001562180-19-004848 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2019. F2 · balance_after: Includes 9,291 restricted stock units. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:55 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,667 | $1.93 | $3,217.31 |
DisclosureSEC source: 0001562180-19-004848 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:00 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-004402 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,609 Underlying: Common Stock · 1,667 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option is fully vested. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:00 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $27.99 | $46,666.66 |
DisclosureSEC source: 0001562180-19-004402 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $27.91 to $28.08. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 9,405 restricted stock units. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:00 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,667 | $1.93 | $3,217.31 |
DisclosureSEC source: 0001562180-19-004402 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2019 Filed Jul 15, 2019 20:04 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-003937 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,276 Underlying: Common Stock · 1,667 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option is fully vested. Read SEC document |
| July 15, 2019 Filed Jul 15, 2019 20:04 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $29.49 | $49,154.16 |
DisclosureSEC source: 0001562180-19-003937 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 16, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $29.42 to $29.7312. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 9,519 restricted stock units. Read SEC document |
| July 15, 2019 Filed Jul 15, 2019 20:04 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,667 | $1.93 | $3,217.31 |
DisclosureSEC source: 0001562180-19-003937 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2019 Filed Jun 17, 2019 20:30 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,667 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-003550 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,943 Underlying: Common Stock · 1,667 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option is fully vested. Read SEC document |
| June 17, 2019 Filed Jun 17, 2019 20:30 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,667 | $32.74 | $54,572.25 |
DisclosureSEC source: 0001562180-19-003550 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F1 · price: This transaction was executed in multiple trades at prices ranging from $32.54 to $33.03. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 9,633 restricted stock units. Read SEC document |
| June 17, 2019 Filed Jun 17, 2019 20:30 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,667 | $1.93 | $3,217.31 |
DisclosureSEC source: 0001562180-19-003550 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 15, 2019 21:21 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 234 | $21.20 | $4,960.80 |
DisclosureSEC source: 0001562180-19-002823 · primarydocument.xml · nonDerivative · entry 4 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F4 · balance_after: Includes 9,747 restricted stock units. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:21 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to Buy) · Derivative | 592 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-19-002823 · primarydocument.xml · derivative · entry 5 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,610 Underlying: Common Stock · 592 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option is fully vested. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:21 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 451 | $20.02 | $9,030.01 |
DisclosureSEC source: 0001562180-19-002823 · primarydocument.xml · nonDerivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,994 F2 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 1,371 RSUs. F3 · price: This transaction was executed in multiple trades at prices ranging from $19.51 to $20.1316. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:21 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 592 | $21.19 | $12,542.88 |
DisclosureSEC source: 0001562180-19-002823 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,445 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.1538 to $21.22. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:21 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 592 | $1.93 | $1,142.56 |
DisclosureSEC source: 0001562180-19-002823 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2019 Filed Mar 19, 2019 20:10 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (right to buy) · Derivative | 19,204 | $0.00 Strike: $24.87 | $0.00 |
DisclosureSEC source: 0001562180-19-001968 · primarydocument.xml · derivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,204 Underlying: Common Stock · 19,204 shares Expires 2029-03-17 F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 17, 2020 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| March 17, 2019 Filed Mar 19, 2019 20:10 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 5,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-001968 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,445 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on March 17, 2020 and vest as to an additional 2.083% of the shares per month for 36 months thereafter. F2 · balance_after: Includes 11,118 restricted stock units. Read SEC document |
| October 31, 2018 Filed Oct 31, 2018 23:44 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,354 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-18-004345 · primarydocument.xml · derivative · entry 4 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,202 Underlying: Common Stock · 1,354 shares Expires 2021-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% @ 1 year, monthly on last day of month thereafter for 3 years (starting in 12th month) beginning on 06-Jul-2011 Read SEC document |
| October 31, 2018 Filed Oct 31, 2018 23:44 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,860 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001562180-18-004345 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,253 Underlying: Common Stock · 1,860 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% @ 1 year, monthly on last day of month thereafter for 3 years (starting in 12th month) beginning on 01-Nov-2011 Read SEC document |
| October 31, 2018 Filed Oct 31, 2018 23:44 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,860 | $2.28 | $4,240.80 |
DisclosureSEC source: 0001562180-18-004345 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,485 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| October 31, 2018 Filed Oct 31, 2018 23:44 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 1,354 | $1.93 | $2,613.22 |
DisclosureSEC source: 0001562180-18-004345 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 5,485 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| May 10, 2018 Filed May 15, 2018 01:00 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (right to buy) · Derivative | 18,700 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001104659-18-033077 · a4.xml · derivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,700 Underlying: Common Stock · 18,700 shares Expires 2028-05-10 F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter. Read SEC document |
| May 10, 2018 Filed May 15, 2018 01:00 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 5,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-033077 · a4.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,598 F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter F2 · balance_after: Represents 31,113 shares of common stock and 5,485 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.